Replimune Group, Inc.
18 Commerce Way
Woburn, MA 01801
July 17, 2018
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Healthcare & Insurance
100 F Street, N.E.
Washington, D.C. 20549-6010
|
Attention: |
Dorrie Yale |
|
|
|
|
Re: |
Replimune Group, Inc. Registration Statement on Form S-1 (Registration No. 333-225846) |
Dear Ms. Yale:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-225846) (the “Registration Statement”) of Replimune Group, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 3:30 p.m., Eastern time, on July 19, 2018, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Gitte J. Blanchet at (617) 951-8211.
[Remainder of page intentionally left blank]
|
|
Very truly yours, | ||
|
|
| ||
|
|
Replimune Group, Inc. | ||
|
|
| ||
|
|
By: |
/s/ Robert Coffin | |
|
|
|
Robert Coffin | |
|
|
|
President and Chief Executive Officer | |
|
|
| ||
|
CC: |
Philip Astley-Sparke, Replimune Group, Inc. | ||
|
|
Timothy J. Corbett, Morgan, Lewis & Bockius LLP | ||
|
|
Gitte J. Blanchet, Morgan, Lewis & Bockius LLP | ||
|
|
William V. Fogg, Cravath, Swaine & Moore LLP | ||
|
|
Johnny G. Skumpija, Cravath, Swaine & Moore LLP | ||
[Signature Page to Request for Acceleration of Effectiveness of Registration Statement]